COMP <GO>
HSDT vs JNJ // ALTMAN Z-SCORE & DEBT/EQUITY
Solana Company (Class A) (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: HSDT 2
— JNJ 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: HSDT
LAST: $2.26 (-1.31%) • MKT CAP: $146.5M
balance-sheet
25.63
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSDT VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSDT | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 67.90% | +28.10 | HSDT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 25.50% | -60.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.27% | 2.97% | -14.24 | JNJ | /fcf-yield <GO> |
| Operating Margin | -60.00% | 34.70% | -94.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 28.50% | -88.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 5.40% | 6.00% | -0.60 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 25.63 | 5.59 | +20.04 | HSDT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.4 | 62.1 | -24.75 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $146.5M | $662.49B | -$662.35B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSDT REV | JNJ REV | HSDT GROSS % | JNJ GROSS % | HSDT FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $548.0K | $94.19B | 98.0% | 67.9% | -$16.5M | $19.70B |
| FY 2024 | $520.0K | $88.82B | -11.9% | 69.1% | -$11.0M | $19.84B |
| FY 2023 | $605.0K | $85.16B | — | — | -$10.4M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSDT // BETA —
JNJ // BETA 1.08